EUVIMEDEUVIMED entdecken
Crossref

Primary Human Gastric Cancer Cells Integrated Hydrogel Microcapsules for Personalized Drug Screening

Letian Meng iD, Lu Fan iD, Shangrui Rao iD, Hongzheng Li, Ji Lin, Weijian Sun, Yu Wang, Jun Cheng, Feika Bian iD, Danhong Hu

ACS Applied Materials & Interfaces · 2026

DOI: 10.1021/acsami.5c22674 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Letian Meng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Antineoplastic Agents, Hydrogels. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Medical Science and Technology Project of Zhejiang Province, Natural Science Foundation of Zhejiang Province, Hangzhou Institute of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Organ-on-a-chip is highly valuable for tumor drug screening, but further exploration in gastric cancer is needed. Here, we propose an innovative platform to cultivate primary gastric cancer cells using microfluidic encapsulation, enabling three-dimensional (3D) tumor growth and clinical drug assessment. We employ microfluidic electrospray technology to mix human primary gastric cancer cells with carboxymethyl cellulose and encapsulate them within alginate core-shell microcapsules. Tumor cells spontaneously form spheroids and proliferate rapidly. These tumor spheroids display multiple characteristics of natural tumors and exhibit heterogeneity within them. Subsequently, microcapsules containing tumor spheroids are combined with a microfluidic chip that is designed with a gradient generator and a culture chamber. This platform enables dynamic perfusion of various chemotherapy drug solutions and the high-throughput generation of drug concentration gradients to assess tumor spheroid sensitivity to these drugs. The findings reveal variations in drug sensitivity among gastric cancer spheroids from different patients. Notably, the drug sensitivity profiles obtained from the tumor spheroid assays show significant consistency with the actual clinical responses of the corresponding patients. These outcomes underscore the potential of integrating microcapsule-cultured tumor spheroid models with microfluidic technology to create a dependable and precise drug evaluation platform for clinical applications in gastric cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsAntineoplastic AgentsHydrogelsHumansSpheroids, CellularCapsulesDrug Screening Assays, AntitumorCell Line, TumorPrecision MedicineAlginates

Stichwörter der Autor:innen

drug screeninggastric cancerhydrogelmicrofluidicstumor spheroids

Substanzen

CapsulesAntineoplastic AgentsHydrogelsAlginates

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
  • Department of Colorectal and Anal. Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
  • Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
  • Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang 325000, China.

ORCID-Profile: Letian Meng, Lu Fan, Shangrui Rao, Feika Bian

Förderung

  • Medical Science and Technology Project of Zhejiang Province
  • Natural Science Foundation of Zhejiang Province
  • Hangzhou Institute of Medical Sciences
  • Nanjing Distinguished Young Scholars Foundation
  • National Basic Research Program of China (973 Program)
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Meng, L., Fan, L., Rao, S., Li, H., Lin, J., Sun, W., Wang, Y., Cheng, J., Bian, F., & Hu, D. (2026). Primary Human Gastric Cancer Cells Integrated Hydrogel Microcapsules for Personalized Drug Screening. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c22674

Vancouver

Meng L, Fan L, Rao S, Li H, Lin J, Sun W, et al. Primary Human Gastric Cancer Cells Integrated Hydrogel Microcapsules for Personalized Drug Screening. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.5c22674

BibTeX
@article{Meng2026,
  author = {Meng, Letian and Fan, Lu and Rao, Shangrui and Li, Hongzheng and Lin, Ji and Sun, Weijian and Wang, Yu and Cheng, Jun and Bian, Feika and Hu, Danhong},
  title = {Primary Human Gastric Cancer Cells Integrated Hydrogel Microcapsules for Personalized Drug Screening},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.5c22674}
}
Kostenlos starten →